nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—CHRM3—nephrolithiasis	0.914	1	CbGaD
Metixene—CHRM4—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00913	0.117	CbGpPWpGaD
Metixene—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00874	0.112	CbGpPWpGaD
Metixene—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00616	0.0786	CbGpPWpGaD
Metixene—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00608	0.0775	CbGpPWpGaD
Metixene—CHRM3—ureter—nephrolithiasis	0.00233	0.865	CbGeAlD
Metixene—CHRM4—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00202	0.0257	CbGpPWpGaD
Metixene—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00193	0.0247	CbGpPWpGaD
Metixene—CHRM4—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0017	0.0216	CbGpPWpGaD
Metixene—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00162	0.0207	CbGpPWpGaD
Metixene—HTR2C—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00158	0.0201	CbGpPWpGaD
Metixene—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00136	0.0174	CbGpPWpGaD
Metixene—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00134	0.0171	CbGpPWpGaD
Metixene—Maprotiline—CHRM3—nephrolithiasis	0.00133	0.291	CrCbGaD
Metixene—HTR2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00132	0.0169	CbGpPWpGaD
Metixene—CHRM4—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00124	0.0158	CbGpPWpGaD
Metixene—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00118	0.0151	CbGpPWpGaD
Metixene—Cyproheptadine—CHRM3—nephrolithiasis	0.00118	0.258	CrCbGaD
Metixene—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00114	0.0146	CbGpPWpGaD
Metixene—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00113	0.0144	CbGpPWpGaD
Metixene—CHRM4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000859	0.011	CbGpPWpGaD
Metixene—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000834	0.0106	CbGpPWpGaD
Metixene—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000831	0.0106	CbGpPWpGaD
Metixene—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000823	0.0105	CbGpPWpGaD
Metixene—Promethazine—CHRM3—nephrolithiasis	0.000723	0.159	CrCbGaD
Metixene—Quetiapine—CHRM3—nephrolithiasis	0.000692	0.152	CrCbGaD
Metixene—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000667	0.00851	CbGpPWpGaD
Metixene—Promazine—CHRM3—nephrolithiasis	0.000636	0.14	CrCbGaD
Metixene—CHRM4—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000604	0.00771	CbGpPWpGaD
Metixene—CHRM4—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000604	0.00771	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000597	0.00761	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000597	0.00761	CbGpPWpGaD
Metixene—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000579	0.00738	CbGpPWpGaD
Metixene—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000579	0.00738	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000572	0.0073	CbGpPWpGaD
Metixene—HTR2C—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000544	0.00694	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000486	0.00621	CbGpPWpGaD
Metixene—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000482	0.00616	CbGpPWpGaD
Metixene—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00047	0.00599	CbGpPWpGaD
Metixene—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000468	0.00598	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000431	0.0055	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00042	0.00536	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000419	0.00534	CbGpPWpGaD
Metixene—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000407	0.0052	CbGpPWpGaD
Metixene—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000407	0.0052	CbGpPWpGaD
Metixene—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000402	0.00513	CbGpPWpGaD
Metixene—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000402	0.00513	CbGpPWpGaD
Metixene—HTR2C—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000393	0.00502	CbGpPWpGaD
Metixene—CHRM4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000389	0.00497	CbGpPWpGaD
Metixene—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000373	0.00476	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000352	0.00449	CbGpPWpGaD
Metixene—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00034	0.00433	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000334	0.00426	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000319	0.00408	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000304	0.00388	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000304	0.00388	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—RGS14—nephrolithiasis	0.000294	0.00375	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.000282	0.00359	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.000267	0.00341	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000263	0.00335	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00026	0.00332	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000259	0.00331	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000256	0.00326	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000254	0.00324	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000243	0.0031	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.000232	0.00296	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.000229	0.00293	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000225	0.00287	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000223	0.00284	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000222	0.00283	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.000208	0.00266	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000199	0.00253	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000198	0.00253	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000198	0.00253	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000198	0.00252	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000196	0.0025	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.00019	0.00243	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000185	0.00237	CbGpPWpGaD
Metixene—CHRM3—renal system—nephrolithiasis	0.000185	0.0687	CbGeAlD
Metixene—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.000181	0.00231	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.00018	0.0023	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00018	0.0023	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000179	0.00229	CbGpPWpGaD
Metixene—CHRM3—kidney—nephrolithiasis	0.000179	0.0664	CbGeAlD
Metixene—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000178	0.00227	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000178	0.00227	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000173	0.0022	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000171	0.00219	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000169	0.00216	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000158	0.00201	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000157	0.002	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000156	0.00199	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000155	0.00198	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000155	0.00197	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000151	0.00193	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000145	0.00185	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000144	0.00183	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000141	0.0018	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000137	0.00175	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000134	0.00171	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000133	0.0017	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000132	0.00169	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	0.000131	0.00168	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	0.00013	0.00166	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000127	0.00162	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	0.000126	0.0016	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000125	0.0016	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	0.000125	0.00159	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000125	0.00159	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000123	0.00158	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.000123	0.00157	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000122	0.00155	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	0.000121	0.00155	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.00012	0.00153	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	0.000119	0.00152	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	0.000114	0.00146	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AGXT—nephrolithiasis	0.000113	0.00144	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000112	0.00143	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000107	0.00136	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	0.000107	0.00136	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.000106	0.00136	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	0.000106	0.00135	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.000105	0.00134	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000103	0.00131	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000102	0.0013	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	0.000102	0.0013	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000102	0.0013	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	9.68e-05	0.00124	CbGpPWpGaD
Metixene—CHRM3—Metabolism—APRT—nephrolithiasis	9.61e-05	0.00123	CbGpPWpGaD
Metixene—CHRM3—Metabolism—SLC26A1—nephrolithiasis	9.61e-05	0.00123	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	9.56e-05	0.00122	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	9.31e-05	0.00119	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	8.85e-05	0.00113	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	8.83e-05	0.00113	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	8.79e-05	0.00112	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	8.74e-05	0.00112	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	8.68e-05	0.00111	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	8.32e-05	0.00106	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	8.32e-05	0.00106	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	8.04e-05	0.00103	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	8.01e-05	0.00102	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	7.94e-05	0.00101	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	7.7e-05	0.000983	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	7.38e-05	0.000941	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.18e-05	0.000916	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	7.18e-05	0.000916	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.16e-05	0.000914	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	7.16e-05	0.000914	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	7.09e-05	0.000905	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.09e-05	0.000905	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PTH—nephrolithiasis	7.04e-05	0.000899	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AQP1—nephrolithiasis	6.85e-05	0.000873	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PTH—nephrolithiasis	6.75e-05	0.000861	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	6.01e-05	0.000767	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PTH—nephrolithiasis	5.5e-05	0.000702	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	5.19e-05	0.000663	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	5.13e-05	0.000654	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PTH—nephrolithiasis	4.75e-05	0.000606	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PTH—nephrolithiasis	4.73e-05	0.000604	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PTH—nephrolithiasis	4.69e-05	0.000598	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	3.54e-05	0.000451	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	3.39e-05	0.000432	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	2.76e-05	0.000352	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	2.38e-05	0.000304	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	2.38e-05	0.000303	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	2.35e-05	0.0003	CbGpPWpGaD
